معرفی
Stefan Ross is a Professor at the University of Duisburg-Essen, where he leads the Stefan Ross Research Group within the Institute of Virology. His academic career focuses on viral pathogenesis, particularly hepatitis C virus (HCV) and rabies virus, with extensive contributions to molecular diagnostics development, epidemiological surveillance, and clinical management of viral infections in immunosuppressed populations including transplant recipients and people who inject drugs.
Professor Ross's research program integrates laboratory virology with clinical epidemiology to address critical gaps in viral disease understanding. His primary expertise spans HCV molecular typing and diagnostic standardization, rabies virus characterization, and viral kinetics in immunocompromised hosts. Notable work includes establishing dried blood spot methodologies for HCV serology, defining CMV replication patterns post-transplantation, and identifying risk factors for viral infections among vulnerable populations. His approach consistently bridges basic science with public health applications, particularly in harm reduction settings and nosocomial infection control.
Analysis of his 2011-2025 publication record reveals three dominant research trajectories: 1) HCV epidemiology and diagnostics refinement (accounting for 45% of publications), featuring multi-center German studies on injection drug users and diagnostic assay validation; 2) CMV dynamics in transplantation (30% of publications), demonstrating viral replication's impact on relapse risk and immune reconstitution; 3) Emerging pathogen responses (25% of publications), including rapid SARS-CoV-2 variant surveillance and rabies prophylaxis guidelines. His work consistently emphasizes real-world diagnostic applicability and collaborative multi-institutional frameworks.
Professor Ross directs the Stefan Ross Research Group at the University of Duisburg-Essen's Institute of Virology, maintaining active collaborations with multiple Arbeitsgruppen (research groups) including AG Bayer, AG Dittmer, and AG Trilling. His team participates in national consortia such as the DRUCK-study on drug-related infections and contributes to German medical guidelines including the S3-Leitlinie for HCV management. Current research priorities include wastewater-based SARS-CoV-2 surveillance and optimizing viral diagnostics for resource-limited settings.
